Cart
sales@molnova.com
H-β-Ala-AMC TFA
CAS No. 201847-54-3
H-β-Ala-AMC TFA( —— )
Catalog No. M21769 CAS No. 201847-54-3
H-β-Ala-AMC TFA is a substrate for aminopeptidase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 40 | In Stock |
|
| 100MG | 54 | In Stock |
|
| 200MG | 91 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameH-β-Ala-AMC TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-β-Ala-AMC TFA is a substrate for aminopeptidase.
-
DescriptionH-β-Ala-AMC TFA is a substrate for aminopeptidase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number201847-54-3
-
Formula Weight360.29
-
Molecular FormulaC??H??F?N?O?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (277.55 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Matthias Cleenewerck, et al. Inhibitor Screening and Enzymatic Activity Determination for Autophagy Target Atg4B Using a Gel Electrophoresis-Based Assay. Eur J Med Chem. 2016 Nov 10;123:631-638.
molnova catalog
related products
-
Physcion 1-O-beta-D-...
Physcion 1-O-beta-D-glucoside is a tumor cell growth inhibitor.
-
CDDO-2P-Im
CDDO-2P-Im, an analog of CDDO-Imidazolide, has a chemopreventive effect. It can reduce the size and severity of the lung tumors in the mouse lung cancer model.
-
DAGLβ-IN-1
DAGLβ-IN-1 is a universal intermediate for designing DAGL tailored activity-based probes, and is an inhibitor of diacylglycerol lipase-β (DAGLβ).
